CorNova is dedicated to bringing breakthrough technologies into clinical practice within interventional medicine. These innovations both enhance current therapies and provide possibilities for entirely new treatment modalities.

Valecor Platinum™ Coronary Stent System The Valecor Platinum Coronary Stent System is manufactured from an advanced cobalt-chromium base material, allowing for some of the thinnest struts available, with a novel design that maximizes flexibility and conformability with uniform expansion and minimal foreshortening. Utilizing a novel ion-based implantation technology called Nanofusion™, the Valecor Platinum stent presents a pure platinum surface to both the lumen and artery wall to provide protection from less biocompatible components inherent in all medical-grade alloys, including cobalt-chromium, with pure platinum. Platinum is an element known for its superior biocompatibility and biostability.

Designed to be the premier bare stent system on the market, the Valecor Coronary Stent System lives up to its name by truly delivering what other stent systems only claim. With its open cell architecture, the Valecor is the perfect stent for use in the most complex of applications. The Valecor Platinum stent provides physicians with a superior treatment option for lesions or patients whose efficacy or safety profile may benefit from a non-drug-eluting stent platform.

The Valecor Platinum Coronary Stent System exhibits excellent deliverability to facilitate treatment to a large array of patients and lesions. The Valecor Platinum outperforms leading stents in independent preclinical studies. The Valecor Platinum Coronary Stent System incorporates a breakthrough surface modification technology, providing a superior treatment option for patients who may benefit from a non-drug-eluting stent platform.

Halo™ Angioplasty Balloon Catheter

CorNova's Halo Angioplasty Balloon™ Catheter is a pre-dilation catheter that also provides diagnostic information about a lesion without substantially increasing time, risk, or cost to the patient.

The Halo Angioplasty Balloon Catheter is an innovative product designed to allow physicians to make more informed decisions about the treatment of specific lesions and enable a new era of advanced interventional treatments. Recent postmortem studies have illustrated that plaque morphology and composition play a significant role in predicting events such as restenosis and stent thrombosis. Unfortunately, fluoroscopy only provides information about the degree of stenosis and no insight into the specifics of the lesion itself.

By utilizing advanced optical technologies, the diagnostic balloon angioplasty catheter provides real-time feedback and diagnosis of the lesion undergoing pre-dilation prior to stent placement. With this new information, the physician will be able to guide both localized and systemic therapies based upon the specific characteristics of the lesion(s) being treated. By integrating this advanced optical analysis within a state-of-the-art angioplasty balloon catheter, the physician can obtain this in-vivo data with no substantially increased time, risk, or cost to the pre-dilation procedure that is already a standard of care in endovascular treatment.

CorNova's Halo Angioplasty Balloon is not currently available for sale.